4th Quarter - Report
HOOPER, LUNDY & BOOKMAN, P.C. for ROCHE DIAGNOSTICS CORPORATION
Income
$50,000
Expenses
—
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
H.R. 4128/S. 2209, The Verifying Leading-edge IVCT Development Act of 2021.
| Lobbyist | Covered position, as disclosed |
|---|---|
| LISA LAYMAN | SPA, Sen Stabenow (2005-2007); SPA, Sen Graham (2001 - 2004); LA, Sen Bryan (2000); LA, Sen Chafee (1997 - 1999); CBO, PA (1992 - 1996) |
Medical/Disease Research/Clinical Labs MED
H.R. 4128/S. 2209, The Verifying Leading-edge IVCT Development Act of 2021.
| Lobbyist | Covered position, as disclosed |
|---|---|
| LISA LAYMAN | SPA, Sen Stabenow (2005-2007); SPA, Sen Graham (2001 - 2004); LA, Sen Bryan (2000); LA, Sen Chafee (1997 - 1999); CBO, PA (1992 - 1996) |
Medicare/Medicaid MMM
S.4449 / HR 8188 Saving Access to Laboratory Services Act (SALSA).
| Lobbyist | Covered position, as disclosed |
|---|---|
| LISA LAYMAN | SPA, Sen Stabenow (2005-2007); SPA, Sen Graham (2001 - 2004); LA, Sen Bryan (2000); LA, Sen Chafee (1997 - 1999); CBO, PA (1992 - 1996) |
Budget/Appropriations BUD
Public Law 117-328, the Consolidated Appropriations Act, 2023, relating to Medicare payment rates for clinical diagnostic laboratory services (H.R. 8188/S. 4449 - SALSA) and regulation of laboratory developed tests (FDASLA Act of 2022).
| Lobbyist | Covered position, as disclosed |
|---|---|
| LISA LAYMAN | Lisa Layman SPA, Sen Stabenow (2005-2007); SPA, Sen Graham (2001 - 2004); LA, Sen Bryan (2000); LA, Sen Chafee (1997 - 1999); CBO, PA (1992 - 1996) |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.